Search - tctmd.com

Displaying 321 - 331 of 331

Sort: Relevancy | Date

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Samir Kapadia and Dr. Horst Sievert About the Results of REDUCE-FMR

September 26, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Carlo Brigouri About REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

September 26, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

September 26, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Michael Mack About COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

September 26, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

September 26, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Dean Kereiakis About the First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

September 26, 2019

CME

Low-Risk Patients: The Changing Face of TAVR

CME

TMVR: Preparing For The Next Revolution 2019

CME

Updates on TAVR in Low-Risk Patients

CME

The Treatment of Mitral Regurgitation in 2019 and Beyond

CME

Advertisement

Dr. C. Michael Gibson Talks With Dr. Samir Kapadia and Dr. Horst Sievert About the Results of REDUCE-FMR

Dr. C. Michael Gibson Talks With Dr. Carlo Brigouri About REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Dr. C. Michael Gibson Talks With Dr. Jonas Lanz About SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis

Dr. C. Michael Gibson Talks With Dr. Michael Mack About COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Dr. C. Michael Gibson Talks With Dr. Dean Kereiakis About the First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment

Low-Risk Patients: The Changing Face of TAVR

TMVR: Preparing For The Next Revolution 2019

Updates on TAVR in Low-Risk Patients

The Treatment of Mitral Regurgitation in 2019 and Beyond

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content